Table 3.
Univariate and adjusted odds ratios for HIV acquisition by HPV multiple infection status at t-1.
| Cases N(%) (N=145) |
Controls N(%) (N=446) |
OR (95% CI) | aOR* (95% CI) | |
|---|---|---|---|---|
| Number of HPV genotypes | ||||
| 0 | 53 (36.6%) | 248 (55.6%) | 1.00 | 1.0 |
| 1 | 34 (23.4%) | 104 (23.3%) | 2.0 [1.2–3.3] | 1.8 [1.0–3.3] |
| 2 | 22 (15.2%) | 49 (11.0%) | 2.9 [1.5– 5.4] | 2.9 [1.4–5.9] |
| 3 | 12 (8.3%) | 21 (4.7%) | 3.0 [1.4–6.5] | 2.5 [1.0–6.0] |
| ≥4 | 24 (16.6%) | 24 (5.4%) | 5.9 [2.9–12.0] | 5.6 [2.5–12.9] |
Controlled for living with partner, primary partner risk, hormonal contraception, condom use, HSV-2, Gonorrhoeae, Chlamydia, Trichomoniasis, BV, and Candida